I’m not sure where you’re getting your info, but good topic. I needs to spend some time learning much more or understanding more.
Thanks for fantastic info I was looking for this information for my mission.
Vzkazy
great info
Datum: 14.02.2024 | Vložil: RobertKib
excellent info 2024
Datum: 24.01.2024 | Vložil: BryanShich
Thanks for wonderful info. What trips can you recommend in 2024? Astro tourism, eco diving, home swapping, train stations are the new food destinations,sports tourism, coolcationing, gig tripping, private group travel?
Buy Amoxil Online
Datum: 15.12.2023 | Vložil: Michaelwap
Buy Bactrim Online - Special offer: Save up to $498 - buy antibiotics online and get discount for all purchased!
an experimental drug
Datum: 20.08.2022 | Vložil: tcsindustryo
unifiram (developmental code name dm-235) is an experimental drug which has antiamnesic effects in animal studies and with significantly higher potency than piracetam. sunifiram is a molecular simplification of unifiram (dm-232). another analogue is sapunifiram (mn-19). as of 2016, sunifiram had not been subjected to toxicology testing, nor to any human clinical trials, and is not approved for use anywhere in the world.
medication for the treatment of serious gram-positive bacterial infections
Datum: 10.04.2022 | Vložil: tcsindustrye
oritavancin, sold under the brand name orbactiv, is a novel semisynthetic glycopeptide antibiotic medication for the treatment of serious gram-positive bacterial infections. its chemical structure as a lipoglycopeptide is similar to vancomycin.
the u.s. food and drug administration (fda) and the european medicines agency (ema) have approved oritavancin for treatment of acute bacterial skin and skin structure infections.
in vitro activity
oritavancin shares certain properties with other members of the glycopeptide class of antibiotics, which includes vancomycin, the current standard of care for serious gram-positive infections in the united states and europe. it possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible gram-positive bacteria, including staphylococcus aureus, mrsa, enterococci, and streptococci. oritavancin was more active than either metronidazole or vancomycin against strains of clostridium difficile tested.
oritavancin has potential use as a therapy for exposure to bacillus anthracis, the gram-positive bacterium that causes anthrax, having demonstrated efficacy in a mouse model both before and after exposure to the bacterium.
mechanism
the 4'-chlorobiphenylmethyl group disrupts the cell membrane of gram-positive bacteria. it also acts by inhibition of transglycosylation and inhibition of transpeptidation.